Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medvantx
AddedFeb 15, 2024
UpdatedJul 17, 2026
Medvantx

Medvantx

Series D

MedVantx: Streamlining medication management and delivery across the US with home solutions.

HQ
San Diego, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Medvantx, founded with the mission to streamline medication management and delivery, focuses on enhancing access to medications and improving patient lives across the United States. The company offers a comprehensive suite of services including Patient Assistance Programs, Cash Pay options, and Pharmacy Services, all supported by their proprietary Medvantx Insights Platform. This platform integrates consultancy expertise and advanced technology to ensure accuracy and efficiency in medication delivery and adherence support.

Notable affiliates include healthcare providers, employers, and manufacturers who collaborate with Medvantx to serve a broad patient base. The company has achieved significant milestones in improving medication accessibility and adherence, positively impacting patient outcomes nationwide. Medvantx's innovative solutions and commitment to advancing healthcare access have established it as a key player in the medication management industry.

Medvantx - Quick Facts

When was Medvantx founded?

Medvantx was founded in 2002.

Where is Medvantx's headquarters located?

Medvantx's headquarters is located in San Diego, CA, US.

How much has Medvantx raised to-date?

As of Dec 31, 2014, Medvantx has raised a total of $27.6M (USD).

How many employees does Medvantx have?

Medvantx has 350 employees as of Feb 4, 2024.

Medvantx - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Medication Management
  • Pharmacy Services
Tags
  • Data
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 5610Restaurants and mobile food service activities
  • 7830Other human resources provision
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 561300Employment Services
  • 561330Professional Employer Organizations
  • 720000Accommodation and Food Services
  • 722000Food Services and Drinking Places
  • 722500Restaurants and Other Eating Places
  • 722510Restaurants and Other Eating Places
  • 722511Full-Service Restaurants
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 325000Chemical Manufacturing
  • 561000Administrative and Support Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5800Eating and drinking places
  • 5810Eating And Drinking Places
  • 5812Eating Places
  • 7360Personnel Supply Services
  • 7363Help Supply Services
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 2830Drugs
  • 2834Pharmaceutical Preparations